全文获取类型
| 收费全文 | 145684篇 |
| 免费 | 10252篇 |
| 国内免费 | 3650篇 |
专业分类
| 耳鼻咽喉 | 1158篇 |
| 儿科学 | 3071篇 |
| 妇产科学 | 2206篇 |
| 基础医学 | 8378篇 |
| 口腔科学 | 3193篇 |
| 临床医学 | 16255篇 |
| 内科学 | 24009篇 |
| 皮肤病学 | 2714篇 |
| 神经病学 | 7102篇 |
| 特种医学 | 4556篇 |
| 外国民族医学 | 39篇 |
| 外科学 | 14882篇 |
| 综合类 | 20763篇 |
| 现状与发展 | 23篇 |
| 一般理论 | 3篇 |
| 预防医学 | 6181篇 |
| 眼科学 | 2227篇 |
| 药学 | 11172篇 |
| 82篇 | |
| 中国医学 | 13918篇 |
| 肿瘤学 | 17654篇 |
出版年
| 2023年 | 2243篇 |
| 2022年 | 3394篇 |
| 2021年 | 6052篇 |
| 2020年 | 5479篇 |
| 2019年 | 7144篇 |
| 2018年 | 6381篇 |
| 2017年 | 6069篇 |
| 2016年 | 5413篇 |
| 2015年 | 5181篇 |
| 2014年 | 9897篇 |
| 2013年 | 12101篇 |
| 2012年 | 8217篇 |
| 2011年 | 8499篇 |
| 2010年 | 7083篇 |
| 2009年 | 6424篇 |
| 2008年 | 6181篇 |
| 2007年 | 6594篇 |
| 2006年 | 5899篇 |
| 2005年 | 5219篇 |
| 2004年 | 4191篇 |
| 2003年 | 3814篇 |
| 2002年 | 3123篇 |
| 2001年 | 2768篇 |
| 2000年 | 2271篇 |
| 1999年 | 1771篇 |
| 1998年 | 1469篇 |
| 1997年 | 1230篇 |
| 1996年 | 1008篇 |
| 1995年 | 938篇 |
| 1994年 | 737篇 |
| 1993年 | 548篇 |
| 1992年 | 491篇 |
| 1991年 | 448篇 |
| 1990年 | 381篇 |
| 1989年 | 335篇 |
| 1988年 | 331篇 |
| 1987年 | 277篇 |
| 1985年 | 863篇 |
| 1984年 | 1243篇 |
| 1983年 | 949篇 |
| 1982年 | 942篇 |
| 1981年 | 931篇 |
| 1980年 | 832篇 |
| 1979年 | 814篇 |
| 1978年 | 683篇 |
| 1977年 | 453篇 |
| 1976年 | 570篇 |
| 1975年 | 460篇 |
| 1974年 | 430篇 |
| 1973年 | 346篇 |
排序方式： 共有10000条查询结果，搜索用时 62 毫秒
81.
An-feng TAO Zheng-hao XU Cheng-hao WU Yi WANG Wei-wei HOU Shi-hong ZHANG Zhong CHEN 《浙江大学学报(医学版)》2015,44(3):315
目的观察比较不同脉冲波形的低频率电刺激对海马电点燃癫痫模型小鼠的作用差异。方法采用电点燃刺激法建立小鼠癫痫模型, 观察正弦波、单相方波、双相方波低频率电刺激对模型小鼠癫痫行为发作及后放电持续时间的影响, 并比较不同时间点给予正弦波低频率电刺激的抗癫痫作用。结果与对照组比较, 正弦波低频率电刺激30 s能降低小鼠海马电点燃癫痫发作等级(2.85 ± 0.27 vs 4.75 ±0.12, P < 0.05)、减少大发作概率(53.6% vs 96.5%, P < 0.01) 和缩短后放电持续时间[(16.22 ± 1.69) s vs (30.29 ± 1.12) s, P < 0.01], 而单相方波和双相方波低频率电刺激30 s没有明显的抗癫痫作用。常用的单相方波低频率电刺激15 min能降低小鼠海马电点燃发作等级(3.58 ± 0.16, P < 0.05)、减少大发作概率(66.7%, P < 0.01);但对海马后放电持续时间及大发作持续时间无影响(均 P>0.05)。此外, 电点燃刺激前预先给予或结束后3 s内给予正弦波低频率电刺激具有明显的抗癫痫作用( P < 0.05或 P < 0.01), 而电点燃刺激结束10 s给予正弦波低频率电刺激则无上述抗癫痫作用。 结论低频率电刺激抗癫痫作用受波形参数的影响, 其中正弦波低频率电刺激能有效抑制小鼠海马电点燃癫痫的发作。 相似文献
82.
《Osteoarthritis and cartilage / OARS, Osteoarthritis Research Society》2020,28(11):1412-1426
83.
Dan Azagury Tara E Mokhtari Luis Garcia Ulysses S Rosas Trit Garg Homero Rivas John Morton 《Surgery》2019,165(3):565-570
Background
Laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding all lead to substantial weight loss in obese patients. Long-term weight loss can be highly variable beyond 1-year postsurgery. This study examines and compares the frequency distribution of weight loss and lack of treatment effect rates after laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding.Methods
A total of 1,331 consecutive patients at a single academic institution were reviewed from a prospectively collected database. Preoperative data collected included demographics, body mass index, and percent excess weight loss. Postoperative BMI and %EWL were collected at 12, 24, and 36 months. Percent excess weight loss was analyzed by the percentiles of excess weight lost, and the distribution of percent excess weight loss was evaluated in 10% increments. Lack of a successful treatment effect was defined as <25% excess weight loss.Results
Of the 1,331 patients, 72.4% (963) underwent laparoscopic Roux-en-Y gastric bypass, 18.3% (243) laparoscopic sleeve gastrectomy, and 9.4%(125) laparoscopic adjustable gastric banding. Mean percent excess weight loss was greatest for laparoscopic Roux-en-Y gastric bypass, followed by laparoscopic sleeve gastrectomy, and then by laparoscopic adjustable gastric banding at every time point: at 2 years mean percent excess weight loss was 77.9± 24.4 for laparoscopic Roux-en-Y gastric bypass, 50.8 ± 25.8 for laparoscopic sleeve gastrectomy, and 40.8± 25.9 for laparoscopic adjustable gastric banding (P < .0001). The rates of a successful treatment effect s for laparoscopic Roux-en-Y gastric bypass, laparoscopic sleeve gastrectomy, and laparoscopic adjustable gastric banding were 0.9%, 5.2%, and 24.3% at 1 year; 0.3%, 11.1%, and 26.0% at 2 years; and 1.0%, 25.3%, and 30.2% at 3 years. At 1 year, the odds ratio of lack of a successful treatment effect of laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass was 6.305 (2.125–19.08; P?=?.0004), the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass was 36.552 (15.64–95.71; P < .0001), and the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy was 5.791 (2.519–14.599; P < .0001). At 2 years, the odds ratio for laparoscopic sleeve gastrectomy versus laparoscopic Roux-en-Y gastric bypass increased to 70.7 (9.4–531.7; P < .0001), the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass increased to 128.1 (16.8–974.3; P < .0001), and the odds ratio for laparoscopic adjustable gastric banding versus laparoscopic sleeve gastrectomy decreased to 1.8 (0.9–3.6; P?=?.09).Conclusion
This study emphasizes the existing variability in weight loss across bariatric procedures as well as in the lack of a treatment effect for each procedure. Although laparoscopic adjustable gastric banding has the greatest rate of a lack of a successful treatment effect, the rate remained stable over 3 years postoperatively. Laparoscopic sleeve gastrectomy showed a doubling in the rate of a lack of a successful treatment effect every year reaching 25% at year 3. The rates for lack of a successful treatment effect for laparoscopic Roux-en-Y gastric bypass remained stable at about 1% for the first 3 years postoperatively. 相似文献84.
85.
Rosario Gulias-Cañizo Anell Lagunes-Guillén Arturo González-Robles Erika Sánchez-Guzmán Federico Castro-Muñozledo 《Burns : journal of the International Society for Burn Injuries》2019,45(2):398-412
Background
Since recent reports have shown that (-)-Epigallocatechin-3-gallate (EGCG) could be used for treating proliferative and inflammatory disorders, we explored its use for the management of corneal chemical burns.Materials and methods
Initially, EGCG was assayed on the rabbit corneal epithelial cell line RCE1(5T5) to establish the best testing conditions, and to avoid unwanted outcomes in the experimental animals. Then, we studied its effects on cell proliferation, cell cycle progression and cell differentiation. Afterwards, we instilled EGCG in experimental grade II corneal alkali burns in mice, three times a day up to 21 days, and evaluated by slit lamp examination and histological sections of corneal epithelial, corneal endothelial and stromal edema, as well as the presence of inflammatory cells and neovascularization.Results
EGCG reduced cell growth and led to a decline in the proportion of proliferative cells in a concentration dependent manner. At 10 μM, EGCG promoted cell differentiation, an effect not related with apoptosis or cytotoxicity. When 10 μM EGCG was instilled in corneal alkali burns in mice three times a day up to 21 days, EGCG significantly reduced corneal opacity and neovascularization. The improved clinical appearance of the cornea was associated to a controlled epithelial growth; epithelial morphology was similar to that observed in normal epithelium and contrasted with the hyperproliferative, desquamating epithelium observed in control burn wounds. EGCG reduced corneal, stromal and endothelial edema, and wound inflammation.Conclusion
This work constitutes the first evidence for the use of EGCG in the acute phase of a corneal alkali burn, representing a possible novel alternative to improve patient outcomes as an add-on therapy. 相似文献86.
87.
《Journal of the American College of Surgeons》2020,230(4):363-370
- Download : Download high-res image (207KB)
- Download : Download full-size image
88.
89.
中西医结合治疗动眼神经麻痹疗效观察 总被引：2，自引：0，他引：2
李春林 《中国实用神经疾病杂志》2015,(10)
目的了解中西医结合法治疗动眼神经麻痹的临床疗效。方法对我院2012-03—2014-03收治的动眼神经麻痹患者进行抽样,择取74例患者随机分成2组,对照组予以基础性西医疗法,实验组在对照组治疗基础上予以中医疗法(包括针刺及服用中药正容汤等),观察2组患者的临床治疗效果。结果实验组总有效率(94.60%)明显高于对照组(64.86%),差异具有统计学意义(P0.05)。结论中西医结合法治疗动眼神经麻痹临床疗效确切,安全系数高,值得临床大力推广使用。 相似文献
90.
石学敏院士从"百病始生,皆源于神,凡刺之法,必先治神"的整体观念论治特发性震颤,治疗以神为本,注重对"神"的调节,提出治疗特发性震颤的新方案。石院士认为本病病位在"脑",脑为髓之海,病机为窍闭神妄,阳缓阴急,致使经筋拘挛弛纵,诱发颤证。治疗应醒神开窍,安神定志,调和阴阳,并强调"醒神、调神、安神"的重要性,形成以脑统神、以神统针、以针调神的学术思想。石学敏院士重视手法的运用和针刺手法量效关系,在其从医数十载的临床治疗中发现,神机异常是百病始生的关键。通过"醒神、调神、安神",在改善特发性震颤患者不自主运动方面均显现其独特优势。 相似文献